Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.
about
Anti-Epidermal Growth Factor Receptor Gene Therapy for GlioblastomaSystemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.Biomaterial-Based Implantable Devices for Cancer Therapy.Monoamines in Glioblastoma: complex biology with therapeutic potential.Localized targeted antiangiogenic drug delivery for glioblastoma.
P2860
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genetic modification of neuron ...... sis treatment of glioblastoma.
@ast
Genetic modification of neuron ...... sis treatment of glioblastoma.
@en
Genetic modification of neuron ...... sis treatment of glioblastoma.
@nl
type
label
Genetic modification of neuron ...... sis treatment of glioblastoma.
@ast
Genetic modification of neuron ...... sis treatment of glioblastoma.
@en
Genetic modification of neuron ...... sis treatment of glioblastoma.
@nl
prefLabel
Genetic modification of neuron ...... sis treatment of glioblastoma.
@ast
Genetic modification of neuron ...... sis treatment of glioblastoma.
@en
Genetic modification of neuron ...... sis treatment of glioblastoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Genetic modification of neuron ...... sis treatment of glioblastoma.
@en
P2093
Bishnu P De
David F Havlicek
Dolan Sondhi
Eric Aronowitz
Esther Z Frenk
Kosuke Funato
Maria J Chiuchiolo
Neil R Hackett
Ronald G Crystal
P2860
P2888
P356
10.1038/CGT.2014.58
P577
2014-12-12T00:00:00Z